Advertisement

Ads Placeholder
Loading...

Dr. Reddy's Laboratories Limited

RDY•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$13.19
$-0.28(-2.08%)
U.S. Market is Open • 10:33

Dr. Reddy's Laboratories Limited (RDY) Stock Overview

Explore Dr. Reddy's Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.1B
P/E Ratio18.18
EPS (TTM)$0.73
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$14.53
3 Months$15.61
1 Year Target$13.53

RDY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dr. Reddy's Laboratories Limited (RDY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.18 and a market capitalization of 11.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.11%
5-Day Change
-2.35%
1-Month Change
-6.53%
3-Month Change
-3.90%
6-Month Change
-5.93%
Year-to-Date (YTD) Change
-3.90%
1-Year Change
0.60%
3-Year Change
16.13%
5-Year Change
7.25%
All-Time (Max) Change
1218.81%

Contact Information

https://www.drreddys.com
91 40 4900 2900
8-2-337, Road No. 3, Hyderabad, NaN, 500034

Company Facts

270,480 Employees
IPO DateApr 11, 2001
CountryIN
Actively Trading

Frequently Asked Questions